Two Sigma Advisers’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,100
| Closed | -$841K | – | 2513 |
|
|
2023
Q1 | $841K | Buy |
+5,100
| New | +$877K | ﹤0.01% | 1714 |
|
|
2022
Q4 | – | Sell |
-7,400
| Closed | -$1.11M | – | 2602 |
|
|
2022
Q3 | $1.11M | Sell |
7,400
-1,400
| -16% | -$233K | ﹤0.01% | 1470 |
|
|
2022
Q2 | $1.45M | Sell |
8,800
-17,600
| -67% | -$3.39M | ﹤0.01% | 1394 |
|
|
2022
Q1 | $5.88M | Buy |
26,400
+9,899
| +60% | +$2.22M | 0.02% | 736 |
|
|
2021
Q4 | $3.92M | Sell |
16,501
-13,000
| -44% | -$3.04M | 0.01% | 882 |
|
|
2021
Q3 | $6.88M | Buy |
29,501
+14,701
| +99% | +$3.08M | 0.02% | 649 |
|
|
2021
Q2 | $3.05M | Sell |
14,800
-2,600
| -15% | -$535K | 0.01% | 1094 |
|
|
2021
Q1 | $3.58M | Sell |
17,400
-13,201
| -43% | -$2.79M | 0.01% | 998 |
|
|
2020
Q4 | $6.56M | Buy |
30,601
+9,501
| +45% | +$1.84M | 0.02% | 722 |
|
|
2020
Q3 | $3.86M | Sell |
21,100
-5,601
| -21% | -$1.05M | 0.01% | 861 |
|
|
2020
Q2 | $4.92M | Buy |
26,701
+2,201
| +9% | +$437K | 0.01% | 806 |
|
|
2020
Q1 | $4.94M | Buy |
24,500
+800
| +3% | +$154K | 0.02% | 716 |
|
|
2019
Q4 | $4.43M | Buy |
+23,700
| New | +$4.08M | 0.01% | 892 |
|
|
2019
Q3 | – | Sell |
-1,100
| Closed | -$277K | – | 2301 |
|
|
2019
Q2 | $277K | Buy |
+1,100
| New | +$255K | ﹤0.01% | 2037 |
|
|
2019
Q1 | – | Sell |
-2,253
| Closed | -$517K | – | 2360 |
|
|
2018
Q4 | $517K | Sell |
2,253
-7,501
| -77% | -$1.85M | ﹤0.01% | 1756 |
|
|
2018
Q3 | $2.76M | Buy |
9,754
+4,900
| +101% | +$1.44M | 0.01% | 1081 |
|
|
2018
Q2 | $1.43M | Buy |
+4,854
| New | +$1.33M | ﹤0.01% | 1454 |
|
|
2017
Q2 | – | Sell |
-3,152
| Closed | -$481K | – | 2311 |
|
|
2017
Q1 | $481K | Buy |
3,152
+200
| +7% | +$29.2K | ﹤0.01% | 1912 |
|
|
2016
Q4 | $435K | Sell |
2,952
-21,302
| -88% | -$3.08M | ﹤0.01% | 1935 |
|
|
2016
Q3 | $3.06M | Sell |
24,254
-26,600
| -52% | -$3.21M | 0.01% | 842 |
|
|
2016
Q2 | $5.73M | Sell |
50,854
-18,300
| -26% | -$1.9M | 0.03% | 506 |
|
|
2016
Q1 | $7.2M | Sell |
69,154
-9,195
| -12% | -$879K | 0.04% | 421 |
|
|
2015
Q4 | $8.84M | Sell |
78,349
-9,305
| -11% | -$1.03M | 0.05% | 342 |
|
|
2015
Q3 | $9.61M | Buy |
87,654
+7,800
| +10% | +$834K | 0.06% | 340 |
|
|
2015
Q2 | $7.64M | Sell |
79,854
-9,401
| -11% | -$878K | 0.06% | 361 |
|
|
2015
Q1 | $8.31M | Sell |
89,255
-9,300
| -9% | -$813K | 0.06% | 358 |
|
|
2014
Q4 | $8.07M | Buy |
98,555
+32,500
| +49% | +$2.49M | 0.06% | 348 |
|
|
2014
Q3 | $4.24M | Sell |
66,055
-21,100
| -24% | -$1.29M | 0.03% | 547 |
|
|
2014
Q2 | $5.3M | Sell |
87,155
-28,500
| -25% | -$1.68M | 0.04% | 456 |
|
|
2014
Q1 | $6.92M | Buy |
115,655
+33,500
| +41% | +$2.06M | 0.06% | 335 |
|
|
2013
Q4 | $5.24M | Buy |
82,155
+28,500
| +53% | +$1.83M | 0.05% | 377 |
|
|
2013
Q3 | $3.65M | Buy |
53,655
+45,800
| +583% | +$3.27M | 0.04% | 421 |
|
|
2013
Q2 | $567K | Buy |
+7,855
| New | +$519K | 0.01% | 1242 |
|
Other funds holding ICUI
Two Sigma Advisers's ICUI Position: Q2 2023 in Review
Two Sigma Advisers sold out of ICU Medical (ICUI) in Q2 2023, closing a stake of 5,100 shares — an estimated $841K sold.
Two Sigma Advisers first reported a position in ICUI in Q2 2013 and held it in 33 quarters. The position peaked at $9.61M in Q3 2015. 231 funds tracked by Wall St. Rank hold ICUI as of Q2 2023.
- Two Sigma Advisers reported no remaining ICU Medical position as of Q2 2023 after selling out during the quarter.
- Two Sigma Advisers sold 5,100 ICU Medical shares in Q2 2023, an estimated $841K.
- Two Sigma Advisers first reported a position in ICU Medical in Q2 2013 and held it in 33 quarters.
- Two Sigma Advisers's ICU Medical position peaked at $9.61M in Q3 2015.
- 231 funds tracked by Wall St. Rank held ICU Medical as of Q2 2023.
Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.